ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

TSVT 2seventy bio Inc

4,76
-0,17 (-3,45%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:25:53
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
2seventy bio Inc TSVT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,17 -3,45% 4,76 23:25:53
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,93 4,60 5,1299 4,76 4,93
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
03.5.202413:00BW2seventy bio to Report First Quarter 2024 Financial Results..
05.4.202415:05BWU.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s..
01.4.202413:30BW2seventy bio Announces Completion of Oncology and Autoimmune..
20.3.202422:04BW2seventy bio Announces Appointments of Eli Casdin and..
15.3.202423:27BWFDA Advisory Committee Votes in Favor of Bristol Myers..
07.3.202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05.3.202413:03EDGAR2Form 8-K - Current report
05.3.202413:00BW2seventy bio Reports Fourth Quarter and Full Year 2023..
01.3.202413:00BW2seventy bio to Report Fourth Quarter and Full Year 2023..
05.2.202422:05BW2seventy bio to Participate in Upcoming Investor Conferences
05.2.202413:02EDGAR2Form 8-K - Current report
05.2.202412:59BWBristol Myers Squibb and 2seventy bio Share Update on U.S...
02.2.202422:54EDGAR2Form 8-K/A - Current report: [Amend]
30.1.202415:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
30.1.202413:48EDGAR2Form 8-K - Current report
30.1.202413:01BW2seventy bio Announces New Strategic Path Forward
05.1.202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
12.12.202313:25EDGAR2Form 8-K - Current report
12.12.202301:30BWAbecma Delivers Sustained Progression-Free Survival Versus..
11.12.202313:00BW2seventy bio to Host Investor Call at 8:00am ET on Tuesday,..
06.12.202320:00BW2seventy bio Reiterates Commitment to Maximizing Shareholder..
01.12.202312:49EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01.12.202312:46EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01.12.202312:43EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
01.12.202312:40EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20.11.202320:31DJNTrending: Bristol Myers Squibb's Blood Cancer Treatment..
20.11.202314:30DJN2seventy Bio Shares Fall Premarket on Abecma Expansion Delay
20.11.202313:56DJNFDA Advisory Panel to Meet on Earlier Use of Abecma From..
20.11.202313:20EDGAR2Form 8-K - Current report
20.11.202312:59BWBristol Myers Squibb and 2seventy bio Provide Update on U.S...
14.11.202313:00BW2seventy bio Reports Third Quarter Financial Results and..
10.11.202313:00BW2seventy bio to Report Third Quarter 2023 Financial Results..
26.10.202313:05EDGAR2Form 8-K - Current report
13.9.202322:03EDGAR2Form 8-K - Current report
12.9.202313:13EDGAR2Form 8-K - Current report
12.9.202313:00BW2seventy bio Announces Strategic Restructuring to Prioritize..
12.9.202312:55BW2seventy bio and JW Therapeutics Announce Intent To Expand..
06.9.202322:54EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.9.202313:00BW2seventy bio to Participate in the 2023 Morgan Stanley..
17.8.202301:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202300:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
15.8.202302:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202313:02EDGAR2Form 8-K - Current report
14.8.202313:00BW2seventy bio Reports Second Quarter Financial Results and..
08.8.202313:00BW2seventy bio to Report Second Quarter 2023 Financial Results..
01.8.202322:15BW2seventy bio to Participate in 2023 Wedbush PacGrow..
27.7.202315:16EDGAR2Form 8-K - Current report
14.6.202313:00BW2seventy bio Announces Clinical Study Pause of PLAT-08 Trial..
07.6.202313:00BW2seventy bio to Participate in Upcoming Investor Conference

Kürzlich von Ihnen besucht

Delayed Upgrade Clock